» Authors » Iony Manitra Razanajatovo

Iony Manitra Razanajatovo

Explore the profile of Iony Manitra Razanajatovo including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 9
Citations 110
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Razanajatovo I, Andrianomiadana L, Habib A, Randrianarisoa M, Razafimanjato H, Rakotondrainipiana M, et al.
Pathogens . 2023 Aug; 12(8). PMID: 37623969
Environmental Enteric Dysfunction (EED) is an associate driver of stunting in poor settings, and intestinal infections indirectly contribute to the pathophysiology underlying EED. Our work aimed at assessing whether enteric...
2.
Razafindratsimandresy R, Joffret M, Raharinantoanina J, Polston P, Andriamamonjy N, Razanajatovo I, et al.
J Med Virol . 2022 Aug; 94(12):5877-5884. PMID: 35977919
To assess circulation of the Sabin 2 poliovirus vaccine strain in Madagascar after its withdrawal from the oral polio vaccine in April 2016, a reinforced poliovirus surveillance was implemented in...
3.
Andriamandimby S, Brook C, Razanajatovo N, Randriambolamanantsoa T, Rakotondramanga J, Rasambainarivo F, et al.
Epidemics . 2021 Dec; 38:100533. PMID: 34896895
As the national reference laboratory for febrile illness in Madagascar, we processed samples from the first epidemic wave of COVID-19, between March and September 2020. We fit generalized additive models...
4.
Onihary A, Razanajatovo I, Rabetafika L, Bastaraud A, Heraud J, Rasolofo V
Viruses . 2021 Sep; 13(9). PMID: 34578294
White Spot Disease (WSD) caused by the (WSSV) is the most devastating viral disease threatening the shrimp culture industry worldwide, including Madagascar. WDS was first reported on the island in...
5.
Andriamandimby S, Brook C, Razanazatovo N, Rakotondramanga J, Rasambainarivo F, Raharimanga V, et al.
medRxiv . 2021 Jul; PMID: 34268517
As the national reference laboratory for febrile illness in Madagascar, we processed samples from the first epidemic wave of COVID-19, between March and September 2020. We fit generalized additive models...
6.
Andriamandimby S, Olive M, Shimakawa Y, Rakotomanana F, Razanajatovo I, Andrianinarivomanana T, et al.
BMC Public Health . 2017 Aug; 17(1):636. PMID: 28778194
Background: WHO developed a global strategy to eliminate hepatitis B by 2030 and set target to treat 80% of people with chronic hepatitis B virus (HBV) infection eligible for antiviral...
7.
Randremanana R, Randrianirina F, Sabatier P, Rakotonirina H, Randriamanantena A, Razanajatovo I, et al.
BMC Infect Dis . 2014 Jul; 14:372. PMID: 24996559
Background: Campylobacter infection is the most common cause of bacterial gastroenteritis in developing countries, including Madagascar. Reports of pathogenicity have not been consistent and repeated exposures over time seem to...
8.
Hamamoto H, Kamura K, Razanajatovo I, Murakami K, Santa T, Sekimizu K
Int J Antimicrob Agents . 2005 Jun; 26(1):38-42. PMID: 15963696
We previously reported that therapeutic drug effects in the silkworm infection model are largely influenced by midgut permeability. In this report, we describe the effects of drug molecular mass and...
9.
Hamamoto H, Kurokawa K, Kaito C, Kamura K, Razanajatovo I, Kusuhara H, et al.
Antimicrob Agents Chemother . 2004 Feb; 48(3):774-9. PMID: 14982763
The injection of bacteria (Staphylococcus aureus, Stenotrophomonas maltophilia) or true fungi (Candida albicans, Candida tropicalis) that are pathogenic to humans into the silkworm hemolymph leads to death of the larvae...